Drugs / 11C-Martinostat
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03721211 | Feb 2020 | breast cancer | Christine Elizabeth Edmonds | Withdrawn | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03549559 | Sep 2018 → Mar 2026 overdue | aortic valve stenosis, diabetes mellitus, heart failure, intrinsic cardiomyopathy | Massachusetts General Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]Martinostat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03721211 ↗ |
| Modality | Diagnostic / imaging agent | “a PET imaging tracer as a possible means of imaging breast cancer” NCT03721211 ↗ |
| Route | Intravenous | “Healthy subjects will receive an IV injection of 11C-Martinostat” NCT03549559 ↗ |